Christian Werner Wichmann

6PUBLICATIONS
43CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Instruments and techniquesBiomedical imagingGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastoma.

|May 13, 2025
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Sagun Parakh, Nhi Huynh, Diana Dong Cao

|Mar 01, 2024
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX.

Katherine A Morgan, Christian W Wichmann, Laura D Osellame

|Feb 20, 2021
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa.

Ingrid Julienne Georgette Burvenich, Yit Wooi Goh, Nancy Guo

|Oct 17, 2020
Automated radiosynthesis of [68 Ga]Ga-PSMA-11 and [177 Lu]Lu-PSMA-617 on the iPHASE MultiSyn module for clinical applications.

Christian W Wichmann, Uwe Ackermann, Stan Poniger

|Jan 25, 2020
Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone.

Christian W Wichmann, Yit Wooi Goh, Adam C Parslow

Pageof 1